Member Info for dunk1973

Yes I'm aware the UK is only a small place. Licensing deals in multiple regions of the world will of course all add up.

But I think RM has been a big error in putting this on the back burner for COPD. That market is massive.

https://coronavirus.data.gov.uk/healthcare

So 135k total admissions to hospital so far this year in the UK.

To me that's says that there is not a large market for SNG drug treatment.

Thoughts anyone?

I keep seeing posts about potential prices on a buyout being anything from £10 to £33 plus

But our broker has a target of £3.60.

What is a realistic price if we get bought out and what price if we just do a partnership deal to produce the drug when approved. I only have 10,800 shares so hope this all goes well from.here.

Hi all

I am new to the forum but I have been invested in ODX dor many months. Following the recenting government announcements very closely. What price could we get to if we have confirmation of an order short term and also long term. I'm trying to get my exit strategy right.

RM is definitely very confident.